Podcast: MDMA CEO Mark Leahey On Industry's Hot Topics

In an exclusive interview with Medtech Insight, MDMA's Mark Leahey – one of industry's top lobbyists – talked about the group's priorities over the past year and its continued work on hot-button issues, including medical device-tax repeal, reimbursement and implementing MDUFA IV provisions. He also discussed the imminent departure of US FDA Commissioner Scott Gottlieb and the recent federal government shutdown.

Podcast

Mark Leahey, CEO of the Medical Device Manufacturer’s Association, recently spoke with Medtech Insight to offer a heads-up on hot-button industry topics being targeted by the group. The top issue for the lobby group continues to be repeal of the medical device tax that he says is on a better footing to succeed despite it failing under previous Congresses.

More from United States

More from North America